Gyeongnam Venture Investment is a venture capital firm established in 2019 and located in Gyeongsangnam-Do, South Korea. The company focuses on investments in a variety of sectors, including the internet, communication, Internet of Things (IoT), electricity, electronics, semiconductors, materials, automobiles, healthcare, biotechnology, and cultural content, which encompasses movies, performances, and musicals. Gyeongnam Venture Investment seeks opportunities in industries with significant growth potential, positioning itself as a key player in supporting innovative businesses in South Korea.
Robos is a robotics company that specializes in developing and operating a hybrid robot system. This system combines self-developed biomaterial machine vision technology with robotics, enabling it to evaluate biological object vision data using Lidar Vision and Open CV-based Object Detection. The company aims to provide core services to various industries, including manufacturing, food, and medical, by offering robot product hardware and software development, robot-applied system design, and custom design services. Through these services, Robos helps businesses improve productivity and efficiency by providing access to advanced robotics technology.
KRISTIN
Series A in 2023
KRISTIN is a supplier of flat, sneakers, and boots.
Reset Company
Series A in 2023
Reset Company focuses on creating sustainable energy solutions and resource circulation systems. The company has developed an autonomous cleaning robot designed specifically for solar panels. This robot operates similarly to a windshield wiper, automatically moving across the surface of solar panels to remove contaminants and snow. By ensuring that solar panels remain clean, the robot helps maximize power generation efficiency and prevents revenue loss for solar power plants. Its design allows for installation on various types of terrain and structures, making it a versatile solution for maintaining the cleanliness and performance of solar energy systems.
Santa
Series A in 2023
Santa is pushing content creation to new limits. Didicast, an easy to use video editing software developed by Santa, is made for content creators that are determined to produce polished videos for anything from education to entertainment. By leveling the learning curve and throwing out the expenses required in traditional content creation, Santa is helping creators from around the world change the world.
ROBOS
Seed Round in 2023
Robos is a robotics company that specializes in developing and operating a hybrid robot system. This system combines self-developed biomaterial machine vision technology with robotics, enabling it to evaluate biological object vision data using Lidar Vision and Open CV-based Object Detection. The company aims to provide core services to various industries, including manufacturing, food, and medical, by offering robot product hardware and software development, robot-applied system design, and custom design services. Through these services, Robos helps businesses improve productivity and efficiency by providing access to advanced robotics technology.
BiomATZ
Seed Round in 2023
BiomATZ is a biotechnology company focused on developing microbiome therapeutics through its innovative platform. This platform isolates and analyzes complex interactions among gut microbiota to create cooperative microbial consortia, which are essential for the development of live biotherapeutic products. BiomATZ aims to enhance personalized medicine and improve gut health, with applications in pharmaceuticals, nutraceuticals, and functional foods. By maintaining a bank of intestinal microorganism strains, the company enables scientists to identify optimal combinations of strains that exhibit either cooperative or competitive relationships, thereby facilitating the advancement of effective microbiome-based therapies.
Biome ATS
Seed Round in 2023
BioM ATS intends to provide the fundamental infrastructure required to progress the complex strain design platform and foster technical collaboration with microbiome firms through proof-of-concept (POC) of the complex strain design technology. It is a strategy to begin the platform business in earnest by the end of the year, with an emphasis on platform advancement and collaboration with industry, academia, research institutes, and the military.
Twinwiz
Seed Round in 2023
Twinwiz is a global materials company specializing in the production of liquid antibacterial and antiviral additives that generate high metal ions. The company operates a research institute focused on developing these functional additives, which can be incorporated into various resins without altering their appearance or physical properties. By enabling clients to use a small quantity of their products, Twinwiz provides colorless and transparent solutions that enhance the antibacterial and antiviral capabilities of a wide range of materials.
UCI Therapeutics
Seed Round in 2022
UCI Therapeutics is a biopharmaceutical company focused on addressing the limitations of current drug therapies. The company specializes in the development of multi-target fusion CAR-NKJ cell therapies, employing a cell-based fusion approach. This innovative method aims to enhance the effectiveness of immune cell therapies specifically for solid tumors, thereby providing new treatment options for patients facing challenges with existing therapies.
Eflow
Venture Round in 2022
Eflow is a hydraulic equipment manufacturing company that focuses on sustainable transportation solutions. It specializes in developing and manufacturing innovative drive propulsion modules that integrate axial magnetic flux motors with various power sources, including lithium batteries and hydrogen fuel cells. Eflow's products aim to enhance mobility through smart technology and filter systems, particularly in the context of hydrogen-powered bicycles. By offering eco-friendly vehicles, Eflow seeks to provide consumers with efficient transportation options that feature extended ranges and reduced operating costs.
KRISTIN
Seed Round in 2022
KRISTIN is a supplier of flat, sneakers, and boots.
CTNS
Seed Round in 2021
CTNS specializes in the development and production of customized secondary battery packs for various applications in the battery industry. The company focuses on manufacturing rechargeable battery packs tailored for small and medium-sized e-mobility solutions, camping and leisure activities, service robots, and logistics robots. By offering next-generation secondary batteries, CTNS aims to provide clients with products that feature high energy density and stability, meeting the growing demands of modern technology and energy needs.
Mr. Dad
Seed Round in 2021
Mr. Dad is an e-commerce marketplace that specializes in selling a wide range of food products. The company offers various items, including meat, eggs, dairy products, fruits, and cooking essentials. By providing customers with access to fresh food items, Mr. Dad aims to meet the diverse dietary needs and preferences of consumers.
Mezoo
Series A in 2021
Mezoo is a medical device manufacturing company focused on developing biomedical sensor technology aimed at enhancing human health through accurate diagnoses. The company has created a compact, patch-type electrocardiogram that can be affixed to a patient’s chest. This device monitors heart activity in real-time, allowing physicians to effectively manage and prevent heart disease. By providing essential health data, Mezoo's technology supports healthcare professionals in delivering timely and informed medical care.
AffyXell Therapeutics
Series A in 2021
AffyXell Therapeutics, established in January 2020 as a joint venture between Avacta and Daewoong, focuses on the development of innovative mesenchymal stem cell (MSC) therapies. The company aims to create next-generation cell and gene therapies specifically designed to treat inflammatory and autoimmune diseases, as well as to prevent organ transplant rejection. By harnessing the therapeutic potential of MSCs, AffyXell seeks to provide health professionals with effective treatment options for a range of challenging medical conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.